Stocks · News reference
Truist Securities Initiates Coverage On Axogen with Buy Rating, Announces Price Target of $60
Truist Securities analyst Ravi Misra initiates coverage on Axogen (NASDAQ:AXGN) with a Buy rating and announces Price Target of $60.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 26, 2026, 1:58 PM
- Checked
- Aug 26, 2026, 1:58 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading